Panitumumab
Vectibix (panitumumab) is an antibody pharmaceutical. Panitumumab was first approved as Vectibix on 2006-09-27. It is used to treat colorectal neoplasms in the USA. It has been approved in Europe to treat colorectal neoplasms. The pharmaceutical is active against epidermal growth factor receptor.
| Trade Name | Vectibix |
|---|---|
| Common Name | Panitumumab |
| Indication | colorectal neoplasms |
| Drug Class | Monoclonal antibodies |
